Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.
Lee WJ, Choi SH, Park CK, Yi KS, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH. Lee WJ, et al. Among authors: park ck, park sh. Acad Radiol. 2012 Nov;19(11):1353-61. doi: 10.1016/j.acra.2012.06.011. Epub 2012 Aug 11. Acad Radiol. 2012. PMID: 22884399 Clinical Trial.
Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.
Sunwoo L, Choi SH, Park CK, Kim JW, Yi KS, Lee WJ, Yoon TJ, Song SW, Kim JE, Kim JY, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Chang KH. Sunwoo L, et al. Among authors: park ck, park sh. J Magn Reson Imaging. 2013 Feb;37(2):351-8. doi: 10.1002/jmri.23838. Epub 2012 Sep 28. J Magn Reson Imaging. 2013. PMID: 23023975
True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.
Song YS, Choi SH, Park CK, Yi KS, Lee WJ, Yun TJ, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Jahng GH, Chang KH. Song YS, et al. Among authors: park ck, park sh. Korean J Radiol. 2013 Jul-Aug;14(4):662-72. doi: 10.3348/kjr.2013.14.4.662. Epub 2013 Jul 17. Korean J Radiol. 2013. PMID: 23901325 Free PMC article.
Glutaminase 2 expression is associated with regional heterogeneity of 5-aminolevulinic acid fluorescence in glioblastoma.
Kim S, Kim JE, Kim YH, Hwang T, Kim SK, Xu WJ, Shin JY, Kim JI, Choi H, Kim HC, Cho HR, Choi A, Chowdhury T, Seo Y, Dho YS, Kim JW, Kim DG, Park SH, Kim H, Choi SH, Park S, Lee SH, Park CK. Kim S, et al. Among authors: park s, park ck, park sh. Sci Rep. 2017 Sep 22;7(1):12221. doi: 10.1038/s41598-017-12557-3. Sci Rep. 2017. PMID: 28939850 Free PMC article.
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.
Hung AL, Maxwell R, Theodros D, Belcaid Z, Mathios D, Luksik AS, Kim E, Wu A, Xia Y, Garzon-Muvdi T, Jackson C, Ye X, Tyler B, Selby M, Korman A, Barnhart B, Park SM, Youn JI, Chowdhury T, Park CK, Brem H, Pardoll DM, Lim M. Hung AL, et al. Among authors: park sm, park ck. Oncoimmunology. 2018 May 24;7(8):e1466769. doi: 10.1080/2162402X.2018.1466769. eCollection 2018. Oncoimmunology. 2018. PMID: 30221069 Free PMC article.
A glioneuronal tumor with CLIP2-MET fusion.
Chowdhury T, Lee Y, Kim S, Yu HJ, Ji SY, Bae JM, Won JK, Shin JH, Weinberger DR, Choi SH, Park CK, Kim JI, Park SH. Chowdhury T, et al. Among authors: park ck, park sh. NPJ Genom Med. 2020 Jun 3;5:24. doi: 10.1038/s41525-020-0131-6. eCollection 2020. NPJ Genom Med. 2020. PMID: 32550005 Free PMC article.
1,917 results